A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice

A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice

Abstract Purpose For the first-line treatment of KRAS mutant non-small cell lung cancer (NSCLC) patients, immunotherapy or platinum-based chemotherapy are the main treatment method. Here, we investigated the clinical efficacy and prognosis those two regimens as first-line treatment in real-world pra...

Full description

Bibliographic Details
Main Authors: Yanxia Liu, Yuan Gao, Ying Wang, Cong Zhao, Zhiyun Zhang, Baolan Li, Tongmei Zhang
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Cancer
Subjects:
KRAS mutation
NSCLC
First-line treatment
Immunotherapy
Antiangiogenic therapy
Online Access:https://doi.org/10.1186/s12885-022-10236-9

Internet

https://doi.org/10.1186/s12885-022-10236-9

Similar Items